Skip to content
PatentBrief
Get alertsTop ↑

Precise Medicine Delivery Device with Priming Control

This patent describes a device for accurately measuring and delivering liquid medicine, using a special mechanism to control how a plunger moves during both initial setup and actual delivery.

Granted 2026ActiveExpires 2042

Original patent title: “Devices and methods for precision dose delivery”

Plain-English explanation by SahiLast reviewed · September 28, 2026

This patent describes a device for accurately measuring and delivering liquid medicine, using a special mechanism to control how a plunger moves during both initial setup and actual delivery. Granted in 2026.

Coverage

What does this patent actually cover?

This device is designed to deliver a specific amount of liquid medicine or other fluid with high accuracy. It includes a main body that holds the liquid, and a plunger rod that pushes a stopper inside the body. The key feature is a special component that precisely controls the forward movement (distal movement) of the plunger rod. This control happens during two distinct phases: a 'priming step' to prepare the device, and a 'subsequent delivery step' to dispense the medicine. This two-step regulation ensures that the device is accurately prepared and then delivers the exact predetermined volume. For example, an insulin pen could use this technology to ensure each dose is consistently accurate, reducing the risk of under- or over-dosing.

The gap

What does this patent NOT cover?

  • Does not cover devices that deliver medicine as a continuous drip without distinct priming and delivery steps controlled by a plunger.
  • Does not cover devices where the dose is determined by factors other than the controlled distal movement of a plunger rod pushing a stopper.
  • Does not cover devices that lack a specific component designed to regulate the plunger rod's movement during both a priming step and a delivery step.
  • Does not cover drug delivery systems that rely on gravity, pumps, or other mechanisms without a physical plunger rod and stopper for dispensing.
  • Does not cover devices where the 'predetermined volume' is not achieved through the precise regulation of plunger rod movement.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

Key facts

Patent numberUS 12734300
StatusActive
FieldBiotech & Medicine
Filed2022
Granted2026
Times cited0
LitigationNone on record
Value · $26K–$84KMinimal

What made this novel

The clever part is the component that regulates the plunger rod's movement during both the initial 'priming step' and the 'delivery step.' This dual-stage regulation ensures accuracy from the very beginning, preventing issues like air bubbles or incomplete initial fills from affecting the final dispensed dose, which was a common challenge in earlier designs.

Devices and methods for precis…(Primary claim)pharmaceuticalmedical devicesbiotechconsumer electronics

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Insulin pens

02

Growth hormone pens

03

Self-injection devices for biologics

04

Auto-injectors for emergency medications

05

Syringe pumps with precise volume control

Why it matters

The bigger picture

Accurate drug delivery is crucial in many medical treatments, especially for conditions like diabetes where precise insulin doses are vital. Errors in dosage can lead to serious health complications. This technology aims to improve patient safety and treatment effectiveness by ensuring consistent and exact delivery of medication, which can reduce the burden on healthcare providers and patients.

Filed

August 1, 2022

Granted

September 15, 2026

Market context

Who's building on this

Companies in this space

Major pharmaceutical companies and medical device manufacturers are continuously developing and refining precision dose delivery systems. Companies like Novo Nordisk, Eli Lilly, Sanofi, and Becton Dickinson (BD) are active in this space, focusing on improving the accuracy, ease of use, and safety of self-administration devices for chronic conditions. Startups in drug delivery technology also frequently innovate in this area, seeking to enhance patient adherence and therapeutic outcomes.

Market impact

This type of invention contributes to the ongoing evolution of drug delivery, particularly for self-administered medications. Improved precision helps build patient trust and reduces medication errors, which can lead to better health outcomes and lower healthcare costs associated with complications from incorrect dosing. It enables the development of more reliable and user-friendly injection devices, expanding the market for at-home treatment options and supporting the growth of biologics and other high-value drug therapies.

Claim 1 — Plain English

What this patent covers

This device is designed to deliver a specific amount of liquid medicine or other fluid with high accuracy. It includes a main body that holds the liquid, and a plunger rod that pushes a stopper inside the body. The key feature is a special component that precisely controls the forward movement (distal movement) of the plunger rod. This control happens during two distinct phases: a 'priming step' to prepare the device, and a 'subsequent delivery step' to dispense the medicine. This two-step regulation ensures that the device is accurately prepared and then delivers the exact predetermined volume. For example, an insulin pen could use this technology to ensure each dose is consistently accurate, reducing the risk of under- or over-dosing.

The clever bit

The clever part is the component that regulates the plunger rod's movement during both the initial 'priming step' and the 'delivery step.' This dual-stage regulation ensures accuracy from the very beginning, preventing issues like air bubbles or incomplete initial fills from affecting the final dispensed dose, which was a common challenge in earlier designs.

What it does not cover

  • Does not cover devices that deliver medicine as a continuous drip without distinct priming and delivery steps controlled by a plunger.
  • Does not cover devices where the dose is determined by factors other than the controlled distal movement of a plunger rod pushing a stopper.
  • Does not cover devices that lack a specific component designed to regulate the plunger rod's movement during both a priming step and a delivery step.
  • Does not cover drug delivery systems that rely on gravity, pumps, or other mechanisms without a physical plunger rod and stopper for dispensing.
  • Does not cover devices where the 'predetermined volume' is not achieved through the precise regulation of plunger rod movement.

Patent timeline

Filing

Application submitted to the patent office

Grant

Patent officially issued

PatentBrief Score

Impact Score

Early stage

Citation count

0/40

No citations yet

Claim breadth

0/20

Narrow claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

20/20

Granted within 5 years

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Minimal

$26K – $84K

Midpoint $53K · 15.8 yr remaining · industry ×2.2

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent

Claim text not yet imported for this patent.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Cite this patent

(2026). Precise Medicine Delivery Device with Priming Control (U.S. Patent No. 12,734,300). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/12734300/devices-and-methods-for-precision-dose-delivery

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US12734300"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

Semantically similar

You might also find these interesting

SEARCH ALL

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary
Explore the landscape:pharmaceutical patents →medical devices patents →biotech patents →

Common Questions

Frequently Asked Questions

What does Precise Medicine Delivery Device with Priming Control cover?

This patent describes a device for accurately measuring and delivering liquid medicine, using a special mechanism to control how a plunger moves during both initial setup and actual delivery.

When does this patent expire?

This patent is expected to expire on September 15, 2046, when the invention enters the public domain.

What problem does this patent solve?

Accurate drug delivery is crucial in many medical treatments, especially for conditions like diabetes where precise insulin doses are vital. Errors in dosage can lead to serious health complications. This technology aims to improve patient safety and treatment effectiveness by ensuring consistent and exact delivery of medication, which can reduce the burden on healthcare providers and patients.

What does this patent NOT cover?

Does not cover devices that deliver medicine as a continuous drip without distinct priming and delivery steps controlled by a plunger.

Patent monitoring

Get notified when new matching patents are published

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: September 28, 2026 · PatentBrief is not a law firm and this is not legal advice.